What to know about tuberculosis as it surfaces in Maine and North Carolina. Who is at risk?
This article reviews key clinical and public health considerations surrounding recent tuberculosis (TB) cases reported in Maine, North Carolina, and California. Although TB remains relatively rare in the United States, it continues to cause more than 1 million deaths annually worldwide and poses ongoing risks, particularly for individuals with weakened immune systems or those who live or work in congregate settings. Experts from Northeastern University outline the biology of Mycobacterium tuberculosis, distinguishing between latent, non-transmissible infection and active disease capable of spreading through respiratory droplets. They emphasize that while most U.S. cases occur among individuals who have immigrated from or traveled to TB-endemic regions, transmission within the country is limited due to robust public health contact tracing. The article summarizes key symptoms, diagnostic approaches, and the prolonged multi-drug treatment required to eradicate this slow-growing pathogen, noting challenges such as adherence and the risk of antibiotic resistance. National surveillance data show long-term declines in incidence since the 1990s, with short-term increases in 2022–2024 followed by preliminary declines in 2025. Overall, the piece underscores that although TB is curable, even a single active case warrants attention due to its potential severity, lengthy treatment course, and public health implications.
Author:
Cynthia McCormick Hibbert, Northeastern Global News
Audiences:
Community Based Organizations, Educators, General Public, Outreach Workers
Topic:
Diagnosis, General TB Information, TB, TB Prevention, TB Treatment
Language:
English
Global resources for the prevention,
management, and elimination of TB.